APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Pressure Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blood Pressure Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchBlood Pressure Medications Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Pressure Medications Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Blood Pressure Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Pressure Medications Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Pressure Medications Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Blood Pressure Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Blood Pressure Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Pressure Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Pressure Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blood Pressure Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Pressure Medications include Chengdu Easton Biopharmaceuticals, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Sanofi, Qingdao Huanghai Pharmaceutical, Novartis, Merck, Jiangsu Jibeier Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood Pressure Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Pressure Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Pressure Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Pressure Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Pressure Medications Segment by Company

Chengdu Easton Biopharmaceuticals

CSPC Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Sanofi

Qingdao Huanghai Pharmaceutical

Novartis

Merck

Jiangsu Jibeier Pharmaceutical

Pfizer

CR Double-Crane

Huahai Pharmaceutical

Jiangsu Hengrui Medicine

Tianjin Pharmaceutical Da Ren Tang Group

Boehringer Ingelheim

Bayer

AstraZeneca

Lupin Pharmaceuticals

Blood Pressure Medications Segment by Type

Angiotensin II Receptor Blockers

Diuretics

Calcium Channel Blockers

Compound Drugs

Beta Blockers

ACE Inhibitors

Others

Blood Pressure Medications Segment by Application

Hospital

Clinic

Others

Blood Pressure Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Pressure Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Pressure Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Pressure Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Pressure Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood Pressure Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Blood Pressure Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Blood Pressure Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Blood Pressure Medications Industry Trends Table 2. Blood Pressure Medications Industry Drivers Table 3. Blood Pressure Medications Industry Opportunities and Challenges Table 4. Blood Pressure Medications Industry Restraints Table 5. Global Blood Pressure Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Blood Pressure Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Blood Pressure Medications Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Blood Pressure Medications Sales Market Share by Manufacturers Table 9. Global Blood Pressure Medications Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Blood Pressure Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Blood Pressure Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Blood Pressure Medications Manufacturers, Product Type & Application Table 13. Global Blood Pressure Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Pressure Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Angiotensin II Receptor Blockers Table 17. Major Manufacturers of Diuretics Table 18. Major Manufacturers of Calcium Channel Blockers Table 19. Major Manufacturers of Compound Drugs Table 20. Major Manufacturers of Beta Blockers Table 21. Major Manufacturers of ACE Inhibitors Table 22. Major Manufacturers of Others Table 23. Global Blood Pressure Medications Sales by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Blood Pressure Medications Sales by Type (2021-2026) & (k units) Table 25. Global Blood Pressure Medications Sales by Type (2027-2032) & (k units) Table 26. Global Blood Pressure Medications Sales Market Share by Type (2021-2026) Table 27. Global Blood Pressure Medications Sales Market Share by Type (2027-2032) Table 28. Global Blood Pressure Medications Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 29. Global Blood Pressure Medications Revenue by Type (2021-2026) & (k units) Table 30. Global Blood Pressure Medications Revenue by Type (2027-2032) & (k units) Table 31. Global Blood Pressure Medications Revenue Market Share by Type (2021-2026) Table 32. Global Blood Pressure Medications Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Hospital Table 34. Major Manufacturers of Clinic Table 35. Major Manufacturers of Others Table 36. Global Blood Pressure Medications Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Blood Pressure Medications Sales by Application (2021-2026) & (k units) Table 38. Global Blood Pressure Medications Sales by Application (2027-2032) & (k units) Table 39. Global Blood Pressure Medications Sales Market Share by Application (2021-2026) Table 40. Global Blood Pressure Medications Sales Market Share by Application (2027-2032) Table 41. Global Blood Pressure Medications Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Blood Pressure Medications Revenue by Application (2021-2026) & (k units) Table 43. Global Blood Pressure Medications Revenue by Application (2027-2032) & (k units) Table 44. Global Blood Pressure Medications Revenue Market Share by Application (2021-2026) Table 45. Global Blood Pressure Medications Revenue Market Share by Application (2027-2032) Table 46. Global Blood Pressure Medications Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Blood Pressure Medications Sales by Region (2021-2026) & (k units) Table 48. Global Blood Pressure Medications Sales Market Share by Region (2021-2026) Table 49. Global Blood Pressure Medications Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Blood Pressure Medications Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Blood Pressure Medications Sales by Country (2021-2026) & (k units) Table 53. North America Blood Pressure Medications Sales by Country (2027-2032) & (k units) Table 54. Europe Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Blood Pressure Medications Sales by Country (2021-2026) & (k units) Table 56. Europe Blood Pressure Medications Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Blood Pressure Medications Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Blood Pressure Medications Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Blood Pressure Medications Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Blood Pressure Medications Sales by Country (2027-2032) & (k units) Table 63. Global Blood Pressure Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Blood Pressure Medications Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Blood Pressure Medications Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Blood Pressure Medications Revenue Market Share by Region (2021-2026) Table 67. Global Blood Pressure Medications Revenue Market Share by Region (2027-2032) Table 68. Chengdu Easton Biopharmaceuticals Company Information Table 69. Chengdu Easton Biopharmaceuticals Business Overview Table 70. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Product Portfolio Table 72. Chengdu Easton Biopharmaceuticals Recent Development Table 73. CSPC Pharmaceutical Group Company Information Table 74. CSPC Pharmaceutical Group Business Overview Table 75. CSPC Pharmaceutical Group Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CSPC Pharmaceutical Group Blood Pressure Medications Product Portfolio Table 77. CSPC Pharmaceutical Group Recent Development Table 78. Shanghai Shyndec Pharmaceutical Company Information Table 79. Shanghai Shyndec Pharmaceutical Business Overview Table 80. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Product Portfolio Table 82. Shanghai Shyndec Pharmaceutical Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanofi Blood Pressure Medications Product Portfolio Table 87. Sanofi Recent Development Table 88. Qingdao Huanghai Pharmaceutical Company Information Table 89. Qingdao Huanghai Pharmaceutical Business Overview Table 90. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Product Portfolio Table 92. Qingdao Huanghai Pharmaceutical Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Novartis Blood Pressure Medications Product Portfolio Table 97. Novartis Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Merck Blood Pressure Medications Product Portfolio Table 102. Merck Recent Development Table 103. Jiangsu Jibeier Pharmaceutical Company Information Table 104. Jiangsu Jibeier Pharmaceutical Business Overview Table 105. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Product Portfolio Table 107. Jiangsu Jibeier Pharmaceutical Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Pfizer Blood Pressure Medications Product Portfolio Table 112. Pfizer Recent Development Table 113. CR Double-Crane Company Information Table 114. CR Double-Crane Business Overview Table 115. CR Double-Crane Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CR Double-Crane Blood Pressure Medications Product Portfolio Table 117. CR Double-Crane Recent Development Table 118. Huahai Pharmaceutical Company Information Table 119. Huahai Pharmaceutical Business Overview Table 120. Huahai Pharmaceutical Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Huahai Pharmaceutical Blood Pressure Medications Product Portfolio Table 122. Huahai Pharmaceutical Recent Development Table 123. Jiangsu Hengrui Medicine Company Information Table 124. Jiangsu Hengrui Medicine Business Overview Table 125. Jiangsu Hengrui Medicine Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jiangsu Hengrui Medicine Blood Pressure Medications Product Portfolio Table 127. Jiangsu Hengrui Medicine Recent Development Table 128. Tianjin Pharmaceutical Da Ren Tang Group Company Information Table 129. Tianjin Pharmaceutical Da Ren Tang Group Business Overview Table 130. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Product Portfolio Table 132. Tianjin Pharmaceutical Da Ren Tang Group Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Blood Pressure Medications Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. Bayer Company Information Table 139. Bayer Business Overview Table 140. Bayer Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Bayer Blood Pressure Medications Product Portfolio Table 142. Bayer Recent Development Table 143. AstraZeneca Company Information Table 144. AstraZeneca Business Overview Table 145. AstraZeneca Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. AstraZeneca Blood Pressure Medications Product Portfolio Table 147. AstraZeneca Recent Development Table 148. Lupin Pharmaceuticals Company Information Table 149. Lupin Pharmaceuticals Business Overview Table 150. Lupin Pharmaceuticals Blood Pressure Medications Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Lupin Pharmaceuticals Blood Pressure Medications Product Portfolio Table 152. Lupin Pharmaceuticals Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Blood Pressure Medications Distributors List Table 156. Blood Pressure Medications Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Blood Pressure Medications Product Image Figure 2. Global Blood Pressure Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Pressure Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Pressure Medications Sales (2021-2032) & (k units) Figure 5. Global Blood Pressure Medications Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Blood Pressure Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Angiotensin II Receptor Blockers Image Figure 9. Diuretics Image Figure 10. Calcium Channel Blockers Image Figure 11. Compound Drugs Image Figure 12. Beta Blockers Image Figure 13. ACE Inhibitors Image Figure 14. Others Image Figure 15. Global Blood Pressure Medications Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Blood Pressure Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Blood Pressure Medications Sales Market Share by Type (2021-2032) Figure 18. Global Blood Pressure Medications Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Blood Pressure Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Blood Pressure Medications Revenue Market Share by Type (2021-2032) Figure 21. Hospital Image Figure 22. Clinic Image Figure 23. Others Image Figure 24. Global Blood Pressure Medications Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Blood Pressure Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Blood Pressure Medications Sales Market Share by Application (2021-2032) Figure 27. Global Blood Pressure Medications Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Blood Pressure Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Blood Pressure Medications Revenue Market Share by Application (2021-2032) Figure 30. North America Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Blood Pressure Medications Sales Market Share by Country (2021-2032) Figure 32. U.S. Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Blood Pressure Medications Sales Market Share by Country (2021-2032) Figure 37. Germany Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Blood Pressure Medications Sales Market Share by Country (2021-2032) Figure 44. China Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Blood Pressure Medications Sales Market Share by Country (2021-2032) Figure 52. Brazil Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Blood Pressure Medications Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Blood Pressure Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Blood Pressure Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Blood Pressure Medications Revenue (2021-2032) & (US$ Million) Figure 63. North America Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Blood Pressure Medications Revenue (2021-2032) & (US$ Million) Figure 65. Europe Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Blood Pressure Medications Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Blood Pressure Medications Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Blood Pressure Medications Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Blood Pressure Medications Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Angiotensin II Receptor Blockers
  • Diuretics
  • Calcium Channel Blockers
  • Compound Drugs
  • Beta Blockers
  • ACE Inhibitors
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chengdu Easton Biopharmaceuticals
  • CSPC Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Sanofi
  • Qingdao Huanghai Pharmaceutical
  • Novartis
  • Merck
  • Jiangsu Jibeier Pharmaceutical
  • Pfizer
  • CR Double-Crane
  • Huahai Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Tianjin Pharmaceutical Da Ren Tang Group
  • Boehringer Ingelheim
  • Bayer
  • AstraZeneca
  • Lupin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Pressure Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Pressure Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Blood Pressure Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Blood Pressure Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Blood Pressure Medications Market Dynamics
  1. 2.1 Blood Pressure Medications Industry Trends
  2. 2.2 Blood Pressure Medications Industry Drivers
  3. 2.3 Blood Pressure Medications Industry Opportunities and Challenges
  4. 2.4 Blood Pressure Medications Industry Restraints
3 Blood Pressure Medications Market by Manufacturers
  1. 3.1 Global Blood Pressure Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Blood Pressure Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Blood Pressure Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Blood Pressure Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood Pressure Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Blood Pressure Medications Manufacturers, Product Type & Application
  7. 3.7 Global Blood Pressure Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood Pressure Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood Pressure Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood Pressure Medications Tier 1, Tier 2, and Tier 3
4 Blood Pressure Medications Market by Type
  1. 4.1 Blood Pressure Medications Type Introduction
  2. 4.1.1 Angiotensin II Receptor Blockers
  3. 4.1.2 Diuretics
  4. 4.1.3 Calcium Channel Blockers
  5. 4.1.4 Compound Drugs
  6. 4.1.5 Beta Blockers
  7. 4.1.6 ACE Inhibitors
  8. 4.1.7 Others
  9. 4.2 Global Blood Pressure Medications Sales by Type
  10. 4.2.1 Global Blood Pressure Medications Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Blood Pressure Medications Sales by Type (2021-2032)
  12. 4.2.3 Global Blood Pressure Medications Sales Market Share by Type (2021-2032)
  13. 4.3 Global Blood Pressure Medications Revenue by Type
  14. 4.3.1 Global Blood Pressure Medications Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Blood Pressure Medications Revenue by Type (2021-2032)
  16. 4.3.3 Global Blood Pressure Medications Revenue Market Share by Type (2021-2032)
5 Blood Pressure Medications Market by Application
  1. 5.1 Blood Pressure Medications Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Blood Pressure Medications Sales by Application
  6. 5.2.1 Global Blood Pressure Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Pressure Medications Sales by Application (2021-2032)
  8. 5.2.3 Global Blood Pressure Medications Sales Market Share by Application (2021-2032)
  9. 5.3 Global Blood Pressure Medications Revenue by Application
  10. 5.3.1 Global Blood Pressure Medications Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood Pressure Medications Revenue by Application (2021-2032)
  12. 5.3.3 Global Blood Pressure Medications Revenue Market Share by Application (2021-2032)
6 Global Blood Pressure Medications Sales by Region
  1. 6.1 Global Blood Pressure Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Pressure Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Pressure Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Blood Pressure Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Blood Pressure Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Blood Pressure Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Blood Pressure Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Blood Pressure Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Blood Pressure Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Blood Pressure Medications Revenue by Region
  1. 7.1 Global Blood Pressure Medications Revenue by Region
  2. 7.1.1 Global Blood Pressure Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Blood Pressure Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Blood Pressure Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Blood Pressure Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Blood Pressure Medications Revenue (2021-2032)
  8. 7.2.2 North America Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Blood Pressure Medications Revenue (2021-2032)
  11. 7.3.2 Europe Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Blood Pressure Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Blood Pressure Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Blood Pressure Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chengdu Easton Biopharmaceuticals
  2. 8.1.1 Chengdu Easton Biopharmaceuticals Company Information
  3. 8.1.2 Chengdu Easton Biopharmaceuticals Business Overview
  4. 8.1.3 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Product Portfolio
  6. 8.1.5 Chengdu Easton Biopharmaceuticals Recent Developments
  7. 8.2 CSPC Pharmaceutical Group
  8. 8.2.1 CSPC Pharmaceutical Group Company Information
  9. 8.2.2 CSPC Pharmaceutical Group Business Overview
  10. 8.2.3 CSPC Pharmaceutical Group Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Pharmaceutical Group Blood Pressure Medications Product Portfolio
  12. 8.2.5 CSPC Pharmaceutical Group Recent Developments
  13. 8.3 Shanghai Shyndec Pharmaceutical
  14. 8.3.1 Shanghai Shyndec Pharmaceutical Company Information
  15. 8.3.2 Shanghai Shyndec Pharmaceutical Business Overview
  16. 8.3.3 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Product Portfolio
  18. 8.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Blood Pressure Medications Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Qingdao Huanghai Pharmaceutical
  26. 8.5.1 Qingdao Huanghai Pharmaceutical Company Information
  27. 8.5.2 Qingdao Huanghai Pharmaceutical Business Overview
  28. 8.5.3 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Product Portfolio
  30. 8.5.5 Qingdao Huanghai Pharmaceutical Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Blood Pressure Medications Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Blood Pressure Medications Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Jiangsu Jibeier Pharmaceutical
  44. 8.8.1 Jiangsu Jibeier Pharmaceutical Company Information
  45. 8.8.2 Jiangsu Jibeier Pharmaceutical Business Overview
  46. 8.8.3 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Product Portfolio
  48. 8.8.5 Jiangsu Jibeier Pharmaceutical Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Blood Pressure Medications Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 CR Double-Crane
  56. 8.10.1 CR Double-Crane Company Information
  57. 8.10.2 CR Double-Crane Business Overview
  58. 8.10.3 CR Double-Crane Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CR Double-Crane Blood Pressure Medications Product Portfolio
  60. 8.10.5 CR Double-Crane Recent Developments
  61. 8.11 Huahai Pharmaceutical
  62. 8.11.1 Huahai Pharmaceutical Company Information
  63. 8.11.2 Huahai Pharmaceutical Business Overview
  64. 8.11.3 Huahai Pharmaceutical Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huahai Pharmaceutical Blood Pressure Medications Product Portfolio
  66. 8.11.5 Huahai Pharmaceutical Recent Developments
  67. 8.12 Jiangsu Hengrui Medicine
  68. 8.12.1 Jiangsu Hengrui Medicine Company Information
  69. 8.12.2 Jiangsu Hengrui Medicine Business Overview
  70. 8.12.3 Jiangsu Hengrui Medicine Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Hengrui Medicine Blood Pressure Medications Product Portfolio
  72. 8.12.5 Jiangsu Hengrui Medicine Recent Developments
  73. 8.13 Tianjin Pharmaceutical Da Ren Tang Group
  74. 8.13.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  75. 8.13.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
  76. 8.13.3 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Product Portfolio
  78. 8.13.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Blood Pressure Medications Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Blood Pressure Medications Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 AstraZeneca
  92. 8.16.1 AstraZeneca Company Information
  93. 8.16.2 AstraZeneca Business Overview
  94. 8.16.3 AstraZeneca Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AstraZeneca Blood Pressure Medications Product Portfolio
  96. 8.16.5 AstraZeneca Recent Developments
  97. 8.17 Lupin Pharmaceuticals
  98. 8.17.1 Lupin Pharmaceuticals Company Information
  99. 8.17.2 Lupin Pharmaceuticals Business Overview
  100. 8.17.3 Lupin Pharmaceuticals Blood Pressure Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lupin Pharmaceuticals Blood Pressure Medications Product Portfolio
  102. 8.17.5 Lupin Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Pressure Medications Value Chain Analysis
  2. 9.1.1 Blood Pressure Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Pressure Medications Production Mode & Process
  6. 9.2 Blood Pressure Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Pressure Medications Distributors
  9. 9.2.3 Blood Pressure Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst